12 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 0.8% per year over the past 5 years.
Operating margin has expanded, at 35.9% in the latest year.
Free cash flow has grown 0.2% per year over the past 5 years.
Financial health
Total debt has grown faster than revenue (27.7% vs -0.8% per year).
Operating income covered interest expense 5.3× in the latest year, down from 8.4× 5 years ago.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$1.2B
-$167M
39.5%
35.9%
-562.6%
-10.1%
$274M
—
$78M
2024
$1.2B
-$430M
38.7%
35.5%
-220.4%
-21.3%
$51M
—
$68M
2023
$1.2B
-$5M
36.6%
34.8%
-0.9%
-0.2%
$95M
—
$96M
2022
$1.7B
$212M
34.2%
27.1%
30.3%
7.7%
$171M
—
$77M
2021
$1.4B
$118M
36.9%
30.3%
17.5%
4.8%
$190M
—
$275M
2020
$1.2B
$181M
38.3%
32.7%
28.3%
7.8%
$270M
$1.3B
$258M
2019
$1.3B
$184M
37.3%
30.7%
34.6%
8.6%
$161M
$1.3B
$57M
2018
$1.1B
$169M
36.8%
28.3%
49.9%
12.9%
$158M
$759M
$78M
2017
$972M
$127M
33.8%
25.0%
45.5%
13.6%
$122M
$455M
$88M
2016
$908M
$35M
30.2%
18.0%
27.7%
4.2%
$71M
$492M
$31M
2015
—
$80M
—
—
15.5%
10.2%
-$29M
—
$32M
2014
—
$129M
—
—
—
18.0%
$37M
—
$20M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$314M
$35M
44.3%
0.0%
75.3%
2.3%
-$24M
—
$97M
Mar '26
$258M
$60M
45.1%
0.0%
153.7%
3.6%
-$12M
—
$95M
Dec '25
$255M
-$85M
34.4%
0.0%
-284.8%
-5.1%
$74M
—
$78M
Sep '25
$333M
$44M
40.2%
0.0%
31.5%
2.4%
$118M
—
$83M
Jun '25
$332M
-$147M
38.6%
0.0%
-121.4%
-7.8%
$67M
—
$77M
Mar '25
$248M
$21M
45.1%
0.0%
8.7%
1.0%
$15M
—
$72M
Dec '24
$263M
$17M
37.9%
30.6%
8.5%
0.8%
$40M
—
$68M
Sep '24
$334M
-$107M
39.4%
33.0%
-50.0%
-4.8%
$29M
—
$136M
Jun '24
$391M
-$284M
31.5%
25.9%
-99.6%
-12.5%
$12M
—
$107M
Mar '24
$340M
-$56M
29.3%
22.6%
-9.9%
-2.2%
-$29M
—
$89M
Dec '23
$372M
-$117M
16.0%
16.6%
-18.5%
-4.5%
$17M
—
$96M
Sep '23
$446M
$25M
28.9%
24.8%
3.5%
0.9%
$72M
—
$85M
Jun '23
$482M
$36M
31.8%
25.1%
5.0%
1.3%
$27M
—
$68M
Mar '23
$393M
$51M
33.2%
26.5%
7.0%
1.8%
-$20M
—
$78M
Dec '22
$384M
$16M
27.5%
19.4%
2.2%
0.6%
$49M
—
$77M
Sep '22
$482M
$75M
36.6%
28.7%
11.9%
3.2%
$64M
—
$72M
Jun '22
$420M
$60M
35.9%
28.8%
9.1%
2.5%
$61M
—
$131M
Mar '22
$383M
$61M
36.0%
31.1%
8.9%
2.5%
-$3M
—
$223M
Dec '21
$336M
$29M
31.3%
23.7%
4.3%
1.2%
$39M
—
$275M
Sep '21
$377M
-$4M
37.6%
31.7%
-0.7%
-0.2%
$75M
—
$269M
Valuation over time
How the market has priced NGVT against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 11.6× (Mar '23) to 7.7× (Dec '23).
The price-to-sales ratio has risen from 1.5× (Mar '23) to 2.1× (Sep '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is NGVT growing its revenue and profit?
Over the past 5 years, Ingevity Corp's revenue has declined 0.8% per year. These are computed facts, not advice.
How much debt does NGVT have?
As of FY2025, Ingevity Corp reported — of total debt against $78M of cash; operating income covered interest expense 5.3×.
What is NGVT's profit margin?
In FY2025, gross margin was 39.5%, operating margin 35.9%, and net margin -14.3%.
What is NGVT's P/E ratio?
As of Sep '26, Ingevity Corp traded at a price-to-earnings ratio of about 7.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.